Treatment of brain metastasis from non-small cell lung cancer with whole brain radiotherapy and Gefitinib in a Chinese population.
about
Role of gefitinib in the targeted treatment of non-small-cell lung cancer in Chinese patientsCombining Whole-Brain Radiotherapy with Gefitinib/Erlotinib for Brain Metastases from Non-Small-Cell Lung Cancer: A Meta-AnalysisAdvances in treatment of brain metastases from primary non-small cell lung cancerIncreased survival with the combination of stereotactic radiosurgery and gefitinib for non-small cell lung cancer brain metastasis patients: a nationwide study in Taiwan.EGFR-TKI therapy for patients with brain metastases from non-small-cell lung cancer: a pooled analysis of published dataWhole brain radiotherapy with a conformational external beam radiation boost for lung cancer patients with 1-3 brain metastasis: a multi institutional studyHemorrhage of brain metastasis from non-small cell lung cancer post gefitinib therapy: two case reports and review of the literatureCritical appraisal of the role of gefitinib in the management of locally advanced or metastatic non-small cell lung cancerBrain metastases in lung adenocarcinoma: impact of EGFR mutation status on incidence and survival.A comparative analysis of EGFR mutation status in association with the efficacy of TKI in combination with WBRT/SRS/surgery plus chemotherapy in brain metastasis from non-small cell lung cancer.Clinical significance of gefitinib antitumor activity in patients with lung adenocarcinoma.Highly sensitive HPLC-DAD method for the assay of gefitinib in patient plasma and cerebrospinal fluid: application to a blood-brain barrier penetration study.Blood-brain barrier permeability of gefitinib in patients with brain metastases from non-small-cell lung cancer before and during whole brain radiation therapy.Effects of an Epithelial Growth Factor Receptor-Tyrosine Kinase Inhibitor Add-on in Stereotactic Radiosurgery for Brain Metastases Originating from Non-Small-Cell Lung CancerIsolated central nervous system progression on Crizotinib: an Achilles heel of non-small cell lung cancer with EML4-ALK translocation?Risk of brain metastasis reduced after erlotinib treatment in advanced pulmonary adenocarcinoma patients with sensitive EGFR mutationPrognostic factors analysis in EGFR mutation-positive non-small cell lung cancer with brain metastases treated with whole brain-radiotherapy and EGFR-tyrosine kinase inhibitors.Temozolomide and/or Erlotinib in the Treatment of Lung Cancer Patients With Progressive Central Nervous System Metastases.Analysis of the benefit of sequential cranial radiotherapy in patients with EGFR mutant non-small cell lung cancer and brain metastasisDevelopment and application of neural stem cells for treating various human neurological diseases in animal models.Chemotherapy and EGFR tyrosine kinase inhibitors for treatment of brain metastases from non-small-cell lung cancer: survival analysis in 210 patients.Profile of ceritinib in the treatment of ALK+ metastatic non-small-cell lung cancer.Systemic treatment of non-small cell lung cancer brain metastasesA Neuro-oncologist's Perspective on Management of Brain Metastases in Patients with EGFR Mutant Non-small Cell Lung Cancer.Combining temozolomide with other antitumor drugs and target-based agents in the treatment of brain metastases: an unending quest or chasing a chimera?Revisiting the role of molecular targeted therapies in patients with brain metastases.A systematic approach to the management of patients with brain metastases of known or unknown primary site.FACT-Br for assessment of quality of life in patients receiving treatment for brain metastases: a literature review.EGF receptor tyrosine kinase inhibitors in the treatment of brain metastases from non-small-cell lung cancer.Health-related quality of life in patients with brain tumors: limitations and additional outcome measures.Brain metastases in non-small-cell lung cancer: better outcomes through current therapies and utilization of molecularly targeted approaches.Systemic therapy of brain metastases.Prophylactic cranial irradiation in non-small cell lung cancer patients: who might be the candidates?Radiotherapy of non-small-cell lung cancer in the era of EGFR gene mutations and EGF receptor tyrosine kinase inhibitors.Systemic therapies in the treatment of non-small-cell lung cancer brain metastases.Non-small cell lung cancer (NSCLC) and central nervous system (CNS) metastases: role of tyrosine kinase inhibitors (TKIs) and evidence in favor or against their use with concurrent cranial radiotherapy.Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of central nervous system metastases from non-small cell lung cancer: the present and the future.Targeted therapy combined with radiotherapy in non-small-cell lung cancer: a review of the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society).Use of Systemic Therapy Concurrent With Cranial Radiotherapy for Cerebral Metastases of Solid Tumors.[China Experts Consensus on the Diagnosis and Treatment of Brain Metastases of Lung Cancer (2017 version)].
P2860
Q26750428-F2BEE6BE-03B9-42DE-AB5F-0F1EF4A788B2Q26752378-D3AB2DE7-9B41-47FA-8A2C-D26A2B81CE18Q27022452-7D1BC180-80A9-438F-A8AD-46E9BF35E173Q30279226-338AFFB6-30EF-4DBE-ACBA-8062704457F6Q30871237-3A9F658E-1057-43A3-B097-66A41CDE118EQ33532301-15F53CDF-51C4-4757-BC1A-8C78A62DC2EEQ33532806-3E6C8432-88E0-454F-94D5-4008BF4E88BAQ33710152-CA9FC61B-63EB-40A0-9AC0-41B43D3E0AA9Q33831950-948CEA81-3CC5-4F02-84F6-FBBDD9631F8BQ34387448-969338BA-1FED-450E-8219-0F25CAF7AA5FQ34582813-F98CD058-26B7-41A6-8B32-053600495CD2Q35642754-B7BE47B6-154D-4650-94F2-7A2483596436Q35781600-D73F9FF8-0098-47D3-A107-A1C336B0AB60Q36241305-763B1A3A-CBFB-4397-AED3-33A114FAA6FFQ36524188-DBC7163A-D361-455E-9030-E49F30D43593Q36575287-026580AB-64F9-4013-A175-C74838661A7BQ36640303-398D82B7-721F-4BAC-B5C5-CC01A4421769Q36682422-AB3D86E4-4CCC-4D69-AE75-F78549FF1FF7Q37119867-9D0EC63D-2E81-471C-A426-2AFD4794ED4FQ37217325-FA37E190-2E64-4BD8-AE5E-3A0ECABF74D5Q37391069-86216802-98CD-46EA-92BF-F1A68F7C2DE9Q37566828-989552F7-893D-44AC-A525-BA007151C4FDQ37727648-2E2D0AFA-94A2-4CC4-B6C2-3ED32B9BF659Q37742623-F8935A4A-4C3E-44A8-B88A-3E0E518039B8Q37870216-F9DC316B-0D62-44A0-A130-BEBF236A61E0Q37904792-2AC4A9F0-C02A-456C-AF7A-DF84C7C7C51BQ37951389-81C8ADD6-84EC-4840-94BD-B02ACDD9F29FQ37958052-2D88A454-E401-440B-9BFB-693032B7BE79Q38068204-765DCC47-1C5C-46B5-A8B8-7F251A481E62Q38105945-33D7B28C-436E-4C01-9B95-21655371D7A4Q38233149-80A390B1-74FE-4C12-AD95-257DFB1397D1Q38285931-A8FD442F-B7DC-46E2-AE77-9A18CC0B517CQ38416214-BC67BD9F-A0A9-46E2-95CF-47C07B469468Q38564088-DD838CF7-6181-4A3E-8C62-97F8CDC8BDD4Q38738053-3E03F5D7-EA95-400B-BAD7-87EB3324F146Q38763104-57E15A99-2A63-442E-90B6-E97D8DC49634Q38763111-1CAEB055-79D9-4348-8A79-1AC9B8896FE0Q38815297-EA9188A2-F1FC-4CF0-A397-67AE8CC181F3Q38975455-11838140-23A0-4769-AB26-7760629E1309Q40372968-C9D13B3E-6D66-4084-A856-7F0ECE5F12A2
P2860
Treatment of brain metastasis from non-small cell lung cancer with whole brain radiotherapy and Gefitinib in a Chinese population.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Treatment of brain metastasis ...... tinib in a Chinese population.
@en
Treatment of brain metastasis ...... tinib in a Chinese population.
@nl
type
label
Treatment of brain metastasis ...... tinib in a Chinese population.
@en
Treatment of brain metastasis ...... tinib in a Chinese population.
@nl
prefLabel
Treatment of brain metastasis ...... tinib in a Chinese population.
@en
Treatment of brain metastasis ...... tinib in a Chinese population.
@nl
P2093
P1433
P1476
Treatment of brain metastasis ...... tinib in a Chinese population.
@en
P2093
Qinghua Deng
Shenglin Ma
P304
P356
10.1016/J.LUNGCAN.2008.10.028
P577
2008-12-16T00:00:00Z